IGT Pharma (V.IGT) Anti-Cancer Blockbuster!! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : IGT Pharma (V.IGT) Anti-Cancer Blockbuster!!

IGT 16.60

-1.1%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stephen O who wrote (60)	2/11/1999 12:53:00 PM
From: Bruce Lock	Read Replies (1) of 86

Re: IGT's Phase 1 human clinical trial... I understand that the Phase 1 human clinical trial of IGT's cancer drug, Anhydrovinblastine (AVLB) will be starting by the end of this month. The objective of the study is to test the safety and dose ranging parameters of AVLB in patients with advanced solid tumors including lung cancer. The study is being conducted at the Roswell Park Cancer Institute in Buffalo, New York. Roswell Park is one of the longest standing cancer facilities in the U.S. and is a National Cancer Institute designated comprehensive cancer center.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next